Phase II study of E7070 in patients with metastatic melanoma

Quantitative Chemical Proteomics for Identifying Candidate Drug Targets

Yoshiya Oda, Takashi Owa, Toshitaka Sato et al. · Analytical Chemistry · 2003 · 190 citations

Proteomic Technology, Quantitative Chemical Proteomics, Drug Target +15

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo

Yoichi Ozawa, Naoko Hata Sugi, Takeshi Nagasu et al. · European Journal of Cancer · 2001 · 132 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +10

Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells

Kazuya Fukuoka, Jitsuo Usuda, Yasuo Iwamoto et al. · Investigational New Drugs · 2001 · 113 citations

Tumor Biology, Oncology, Cell Cycle Progression +8

Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced Cancer

Éric Raymond, W.W. ten Bokkel Huinink, Jos H. Beijnen et al. · Journal of Clinical Oncology · 2002 · 64 citations

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG)

Cornelis J. A. Punt, P. Fumoleau, Baudouin van de Walle et al. · Annals of Oncology · 2001 · 60 citations

Oncology, Solid Tumors, Pharmacology +7